Literature DB >> 31753595

Microbe-MUC1 Crosstalk in Cancer-Associated Infections.

Mukulika Bose1, Pinku Mukherjee2.   

Abstract

Infection-associated cancers account for ∼20% of all malignancies. Understanding the molecular mechanisms underlying infection-associated malignancies may help in developing diagnostic biomarkers and preventative vaccines against malignancy. During infection, invading microbes interact with host mucins lining the glandular epithelial cells and trigger inflammation. MUC1 is a transmembrane mucin glycoprotein that is present on the surface of almost all epithelial cells, and is known to interact with invading microbes. This interaction can trigger pro- or anti-inflammatory responses depending on the microbe and the cell type. In this review we summarize the mechanisms of microbe and MUC1 interactions, and highlight how MUC1 plays contrasting roles in different cells. We also share perspectives on future research that may support clinical advances in infection-associated cancers.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  glycome; inflammation; peptidomimetic; sugar code

Mesh:

Substances:

Year:  2019        PMID: 31753595     DOI: 10.1016/j.molmed.2019.10.003

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  11 in total

1.  Immunogenetics of Lupus Erythematosus.

Authors:  Begüm Ünlü; Ümit Türsen; Navid Jabalameli; Fahimeh Abdollahimajd; Fateme Rajabi
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 2.  The therapeutic potential of inorganic polyphosphate: A versatile physiological polymer to control coronavirus disease (COVID-19).

Authors:  Hadrian Schepler; Xiaohong Wang; Meik Neufurth; Shunfeng Wang; Heinz C Schröder; Werner E G Müller
Journal:  Theranostics       Date:  2021-04-15       Impact factor: 11.556

Review 3.  Potential of Anti-MUC1 Antibodies as a Targeted Therapy for Gastrointestinal Cancers.

Authors:  Mukulika Bose; Pinku Mukherjee
Journal:  Vaccines (Basel)       Date:  2020-11-05

Review 4.  Alpha-Fetoprotein Binding Mucin and Scavenger Receptors: An Available Bio-Target for Treating Cancer.

Authors:  Bo Lin; Qiujiao Wang; Kun Liu; Xu Dong; Mingyue Zhu; Mengsen Li
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

Review 5.  Mucin signature as a potential tool to predict susceptibility to COVID-19.

Authors:  Mukulika Bose; Bhaskar Mitra; Pinku Mukherjee
Journal:  Physiol Rep       Date:  2021-01

Review 6.  Novel insights into the roles and therapeutic implications of MUC1 oncoprotein via regulating proteins and non-coding RNAs in cancer.

Authors:  Wei Li; Yineng Han; Chenmin Sun; Xue Li; Junhua Zheng; Jianping Che; Xudong Yao; Donald Kufe
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.556

7.  The prognostic value of arginase-1 and glypican-3 expression levels in patients after surgical intrahepatic cholangiocarcinoma resection.

Authors:  Zeyuan Qiang; Haofeng Zhang; Shuai Jin; Cao Yan; Zhen Li; Lianyuan Tao; Haibo Yu
Journal:  World J Surg Oncol       Date:  2021-10-29       Impact factor: 2.754

8.  Overexpression of MUC1 Induces Non-Canonical TGF-β Signaling in Pancreatic Ductal Adenocarcinoma.

Authors:  Mukulika Bose; Priyanka Grover; Alexa J Sanders; Ru Zhou; Mohammad Ahmad; Sophia Shwartz; Priyanka Lala; Sritama Nath; Mahboubeh Yazdanifar; Cory Brouwer; Pinku Mukherjee
Journal:  Front Cell Dev Biol       Date:  2022-02-14

9.  Repression of MUC1 Promotes Expansion and Suppressive Function of Myeloid-Derived Suppressor Cells in Pancreatic and Breast Cancer Murine Models.

Authors:  Mahnaz Sahraei; Mukulika Bose; J Alexa Sanders; Chandrav De; Lopamudra DasRoy; Sritama Nath; Cory R Brouwer; Pinku Mukherjee
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923

Review 10.  MUC1: Structure, Function, and Clinic Application in Epithelial Cancers.

Authors:  Wenqing Chen; Zhu Zhang; Shiqing Zhang; Peili Zhu; Joshua Ka-Shun Ko; Ken Kin-Lam Yung
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.